Global Mental Disorders Drugs Market Growth 2023-2029

February 2023 | 97 pages | ID: GAC0A203FE52EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Mental Disorders Drugs Industry Forecast” looks at past sales and reviews total world Mental Disorders Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Mental Disorders Drugs sales for 2023 through 2029. With Mental Disorders Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mental Disorders Drugs industry.

This Insight Report provides a comprehensive analysis of the global Mental Disorders Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mental Disorders Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mental Disorders Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mental Disorders Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mental Disorders Drugs.

The global Mental Disorders Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Mental Disorders Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Mental Disorders Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Mental Disorders Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Mental Disorders Drugs players cover Johnson & Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb and Abbott Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Mental Disorders Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Drugs for Schizophrenia
• Antidepressants
• Antipsychotics
• Anxiolytics
• Drugs for the Treatment of Substance and Alcohol Addiction
• Drugs for Childhood and Adolescent Mental Illness
• Drugs to Treat Cognitive Disorders
• Sleep Disorders
• Others

Segmentation by application

• Children
• Adolescents
• Adults

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson
• Pfizer
• Eli Lilly
• GlaxoSmithKline
• AstraZeneca
• Bristol-Myers Squibb
• Abbott Laboratories

Key Questions Addressed in this Report

What is the 10-year outlook for the global Mental Disorders Drugs market?

What factors are driving Mental Disorders Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Mental Disorders Drugs market opportunities vary by end market size?

How does Mental Disorders Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mental Disorders Drugs Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Mental Disorders Drugs by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Mental Disorders Drugs by Country/Region, 2018, 2022 & 2029
2.2 Mental Disorders Drugs Segment by Type
  2.2.1 Drugs for Schizophrenia
  2.2.2 Antidepressants
  2.2.3 Antipsychotics
  2.2.4 Anxiolytics
  2.2.5 Drugs for the Treatment of Substance and Alcohol Addiction
  2.2.6 Drugs for Childhood and Adolescent Mental Illness
  2.2.7 Drugs to Treat Cognitive Disorders
  2.2.8 Sleep Disorders
  2.2.9 Others
2.3 Mental Disorders Drugs Sales by Type
  2.3.1 Global Mental Disorders Drugs Sales Market Share by Type (2018-2023)
  2.3.2 Global Mental Disorders Drugs Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Mental Disorders Drugs Sale Price by Type (2018-2023)
2.4 Mental Disorders Drugs Segment by Application
  2.4.1 Children
  2.4.2 Adolescents
  2.4.3 Adults
2.5 Mental Disorders Drugs Sales by Application
  2.5.1 Global Mental Disorders Drugs Sale Market Share by Application (2018-2023)
  2.5.2 Global Mental Disorders Drugs Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Mental Disorders Drugs Sale Price by Application (2018-2023)

3 GLOBAL MENTAL DISORDERS DRUGS BY COMPANY

3.1 Global Mental Disorders Drugs Breakdown Data by Company
  3.1.1 Global Mental Disorders Drugs Annual Sales by Company (2018-2023)
  3.1.2 Global Mental Disorders Drugs Sales Market Share by Company (2018-2023)
3.2 Global Mental Disorders Drugs Annual Revenue by Company (2018-2023)
  3.2.1 Global Mental Disorders Drugs Revenue by Company (2018-2023)
  3.2.2 Global Mental Disorders Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Mental Disorders Drugs Sale Price by Company
3.4 Key Manufacturers Mental Disorders Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Mental Disorders Drugs Product Location Distribution
  3.4.2 Players Mental Disorders Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MENTAL DISORDERS DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Mental Disorders Drugs Market Size by Geographic Region (2018-2023)
  4.1.1 Global Mental Disorders Drugs Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Mental Disorders Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mental Disorders Drugs Market Size by Country/Region (2018-2023)
  4.2.1 Global Mental Disorders Drugs Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Mental Disorders Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mental Disorders Drugs Sales Growth
4.4 APAC Mental Disorders Drugs Sales Growth
4.5 Europe Mental Disorders Drugs Sales Growth
4.6 Middle East & Africa Mental Disorders Drugs Sales Growth

5 AMERICAS

5.1 Americas Mental Disorders Drugs Sales by Country
  5.1.1 Americas Mental Disorders Drugs Sales by Country (2018-2023)
  5.1.2 Americas Mental Disorders Drugs Revenue by Country (2018-2023)
5.2 Americas Mental Disorders Drugs Sales by Type
5.3 Americas Mental Disorders Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mental Disorders Drugs Sales by Region
  6.1.1 APAC Mental Disorders Drugs Sales by Region (2018-2023)
  6.1.2 APAC Mental Disorders Drugs Revenue by Region (2018-2023)
6.2 APAC Mental Disorders Drugs Sales by Type
6.3 APAC Mental Disorders Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Mental Disorders Drugs by Country
  7.1.1 Europe Mental Disorders Drugs Sales by Country (2018-2023)
  7.1.2 Europe Mental Disorders Drugs Revenue by Country (2018-2023)
7.2 Europe Mental Disorders Drugs Sales by Type
7.3 Europe Mental Disorders Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mental Disorders Drugs by Country
  8.1.1 Middle East & Africa Mental Disorders Drugs Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Mental Disorders Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Mental Disorders Drugs Sales by Type
8.3 Middle East & Africa Mental Disorders Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mental Disorders Drugs
10.3 Manufacturing Process Analysis of Mental Disorders Drugs
10.4 Industry Chain Structure of Mental Disorders Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Mental Disorders Drugs Distributors
11.3 Mental Disorders Drugs Customer

12 WORLD FORECAST REVIEW FOR MENTAL DISORDERS DRUGS BY GEOGRAPHIC REGION

12.1 Global Mental Disorders Drugs Market Size Forecast by Region
  12.1.1 Global Mental Disorders Drugs Forecast by Region (2024-2029)
  12.1.2 Global Mental Disorders Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mental Disorders Drugs Forecast by Type
12.7 Global Mental Disorders Drugs Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Information
  13.1.2 Johnson & Johnson Mental Disorders Drugs Product Portfolios and Specifications
  13.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Johnson & Johnson Main Business Overview
  13.1.5 Johnson & Johnson Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Mental Disorders Drugs Product Portfolios and Specifications
  13.2.3 Pfizer Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
13.3 Eli Lilly
  13.3.1 Eli Lilly Company Information
  13.3.2 Eli Lilly Mental Disorders Drugs Product Portfolios and Specifications
  13.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Eli Lilly Main Business Overview
  13.3.5 Eli Lilly Latest Developments
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Information
  13.4.2 GlaxoSmithKline Mental Disorders Drugs Product Portfolios and Specifications
  13.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 GlaxoSmithKline Main Business Overview
  13.4.5 GlaxoSmithKline Latest Developments
13.5 AstraZeneca
  13.5.1 AstraZeneca Company Information
  13.5.2 AstraZeneca Mental Disorders Drugs Product Portfolios and Specifications
  13.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 AstraZeneca Main Business Overview
  13.5.5 AstraZeneca Latest Developments
13.6 Bristol-Myers Squibb
  13.6.1 Bristol-Myers Squibb Company Information
  13.6.2 Bristol-Myers Squibb Mental Disorders Drugs Product Portfolios and Specifications
  13.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Bristol-Myers Squibb Main Business Overview
  13.6.5 Bristol-Myers Squibb Latest Developments
13.7 Abbott Laboratories
  13.7.1 Abbott Laboratories Company Information
  13.7.2 Abbott Laboratories Mental Disorders Drugs Product Portfolios and Specifications
  13.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Abbott Laboratories Main Business Overview
  13.7.5 Abbott Laboratories Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Mental Disorders Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mental Disorders Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Drugs for Schizophrenia
Table 4. Major Players of Antidepressants
Table 5. Major Players of Antipsychotics
Table 6. Major Players of Anxiolytics
Table 7. Major Players of Drugs for the Treatment of Substance and Alcohol Addiction
Table 8. Major Players of Drugs for Childhood and Adolescent Mental Illness
Table 9. Major Players of Drugs to Treat Cognitive Disorders
Table 10. Major Players of Sleep Disorders
Table 11. Major Players of Others
Table 12. Global Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 13. Global Mental Disorders Drugs Sales Market Share by Type (2018-2023)
Table 14. Global Mental Disorders Drugs Revenue by Type (2018-2023) & ($ million)
Table 15. Global Mental Disorders Drugs Revenue Market Share by Type (2018-2023)
Table 16. Global Mental Disorders Drugs Sale Price by Type (2018-2023) & (USD/Pcs)
Table 17. Global Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 18. Global Mental Disorders Drugs Sales Market Share by Application (2018-2023)
Table 19. Global Mental Disorders Drugs Revenue by Application (2018-2023)
Table 20. Global Mental Disorders Drugs Revenue Market Share by Application (2018-2023)
Table 21. Global Mental Disorders Drugs Sale Price by Application (2018-2023) & (USD/Pcs)
Table 22. Global Mental Disorders Drugs Sales by Company (2018-2023) & (K Units)
Table 23. Global Mental Disorders Drugs Sales Market Share by Company (2018-2023)
Table 24. Global Mental Disorders Drugs Revenue by Company (2018-2023) ($ Millions)
Table 25. Global Mental Disorders Drugs Revenue Market Share by Company (2018-2023)
Table 26. Global Mental Disorders Drugs Sale Price by Company (2018-2023) & (USD/Pcs)
Table 27. Key Manufacturers Mental Disorders Drugs Producing Area Distribution and Sales Area
Table 28. Players Mental Disorders Drugs Products Offered
Table 29. Mental Disorders Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Mental Disorders Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 33. Global Mental Disorders Drugs Sales Market Share Geographic Region (2018-2023)
Table 34. Global Mental Disorders Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 35. Global Mental Disorders Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 36. Global Mental Disorders Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 37. Global Mental Disorders Drugs Sales Market Share by Country/Region (2018-2023)
Table 38. Global Mental Disorders Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 39. Global Mental Disorders Drugs Revenue Market Share by Country/Region (2018-2023)
Table 40. Americas Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)
Table 41. Americas Mental Disorders Drugs Sales Market Share by Country (2018-2023)
Table 42. Americas Mental Disorders Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 43. Americas Mental Disorders Drugs Revenue Market Share by Country (2018-2023)
Table 44. Americas Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 45. Americas Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 46. APAC Mental Disorders Drugs Sales by Region (2018-2023) & (K Units)
Table 47. APAC Mental Disorders Drugs Sales Market Share by Region (2018-2023)
Table 48. APAC Mental Disorders Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 49. APAC Mental Disorders Drugs Revenue Market Share by Region (2018-2023)
Table 50. APAC Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 51. APAC Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 52. Europe Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)
Table 53. Europe Mental Disorders Drugs Sales Market Share by Country (2018-2023)
Table 54. Europe Mental Disorders Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 55. Europe Mental Disorders Drugs Revenue Market Share by Country (2018-2023)
Table 56. Europe Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 57. Europe Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 58. Middle East & Africa Mental Disorders Drugs Sales by Country (2018-2023) & (K Units)
Table 59. Middle East & Africa Mental Disorders Drugs Sales Market Share by Country (2018-2023)
Table 60. Middle East & Africa Mental Disorders Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 61. Middle East & Africa Mental Disorders Drugs Revenue Market Share by Country (2018-2023)
Table 62. Middle East & Africa Mental Disorders Drugs Sales by Type (2018-2023) & (K Units)
Table 63. Middle East & Africa Mental Disorders Drugs Sales by Application (2018-2023) & (K Units)
Table 64. Key Market Drivers & Growth Opportunities of Mental Disorders Drugs
Table 65. Key Market Challenges & Risks of Mental Disorders Drugs
Table 66. Key Industry Trends of Mental Disorders Drugs
Table 67. Mental Disorders Drugs Raw Material
Table 68. Key Suppliers of Raw Materials
Table 69. Mental Disorders Drugs Distributors List
Table 70. Mental Disorders Drugs Customer List
Table 71. Global Mental Disorders Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 72. Global Mental Disorders Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Americas Mental Disorders Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Americas Mental Disorders Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. APAC Mental Disorders Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 76. APAC Mental Disorders Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 77. Europe Mental Disorders Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 78. Europe Mental Disorders Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 79. Middle East & Africa Mental Disorders Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 80. Middle East & Africa Mental Disorders Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 81. Global Mental Disorders Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 82. Global Mental Disorders Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 83. Global Mental Disorders Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 84. Global Mental Disorders Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 85. Johnson & Johnson Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Johnson & Johnson Mental Disorders Drugs Product Portfolios and Specifications
Table 87. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Johnson & Johnson Main Business
Table 89. Johnson & Johnson Latest Developments
Table 90. Pfizer Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Mental Disorders Drugs Product Portfolios and Specifications
Table 92. Pfizer Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Eli Lilly Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Eli Lilly Mental Disorders Drugs Product Portfolios and Specifications
Table 97. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Eli Lilly Main Business
Table 99. Eli Lilly Latest Developments
Table 100. GlaxoSmithKline Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Mental Disorders Drugs Product Portfolios and Specifications
Table 102. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. AstraZeneca Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. AstraZeneca Mental Disorders Drugs Product Portfolios and Specifications
Table 107. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Latest Developments
Table 110. Bristol-Myers Squibb Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Bristol-Myers Squibb Mental Disorders Drugs Product Portfolios and Specifications
Table 112. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. Bristol-Myers Squibb Main Business
Table 114. Bristol-Myers Squibb Latest Developments
Table 115. Abbott Laboratories Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Abbott Laboratories Mental Disorders Drugs Product Portfolios and Specifications
Table 117. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Abbott Laboratories Main Business
Table 119. Abbott Laboratories Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Mental Disorders Drugs
Figure 2. Mental Disorders Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mental Disorders Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mental Disorders Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mental Disorders Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Drugs for Schizophrenia
Figure 10. Product Picture of Antidepressants
Figure 11. Product Picture of Antipsychotics
Figure 12. Product Picture of Anxiolytics
Figure 13. Product Picture of Drugs for the Treatment of Substance and Alcohol Addiction
Figure 14. Product Picture of Drugs for Childhood and Adolescent Mental Illness
Figure 15. Product Picture of Drugs to Treat Cognitive Disorders
Figure 16. Product Picture of Sleep Disorders
Figure 17. Product Picture of Others
Figure 18. Global Mental Disorders Drugs Sales Market Share by Type in 2022
Figure 19. Global Mental Disorders Drugs Revenue Market Share by Type (2018-2023)
Figure 20. Mental Disorders Drugs Consumed in Children
Figure 21. Global Mental Disorders Drugs Market: Children (2018-2023) & (K Units)
Figure 22. Mental Disorders Drugs Consumed in Adolescents
Figure 23. Global Mental Disorders Drugs Market: Adolescents (2018-2023) & (K Units)
Figure 24. Mental Disorders Drugs Consumed in Adults
Figure 25. Global Mental Disorders Drugs Market: Adults (2018-2023) & (K Units)
Figure 26. Global Mental Disorders Drugs Sales Market Share by Application (2022)
Figure 27. Global Mental Disorders Drugs Revenue Market Share by Application in 2022
Figure 28. Mental Disorders Drugs Sales Market by Company in 2022 (K Units)
Figure 29. Global Mental Disorders Drugs Sales Market Share by Company in 2022
Figure 30. Mental Disorders Drugs Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Mental Disorders Drugs Revenue Market Share by Company in 2022
Figure 32. Global Mental Disorders Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Mental Disorders Drugs Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Mental Disorders Drugs Sales 2018-2023 (K Units)
Figure 35. Americas Mental Disorders Drugs Revenue 2018-2023 ($ Millions)
Figure 36. APAC Mental Disorders Drugs Sales 2018-2023 (K Units)
Figure 37. APAC Mental Disorders Drugs Revenue 2018-2023 ($ Millions)
Figure 38. Europe Mental Disorders Drugs Sales 2018-2023 (K Units)
Figure 39. Europe Mental Disorders Drugs Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Mental Disorders Drugs Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Mental Disorders Drugs Revenue 2018-2023 ($ Millions)
Figure 42. Americas Mental Disorders Drugs Sales Market Share by Country in 2022
Figure 43. Americas Mental Disorders Drugs Revenue Market Share by Country in 2022
Figure 44. Americas Mental Disorders Drugs Sales Market Share by Type (2018-2023)
Figure 45. Americas Mental Disorders Drugs Sales Market Share by Application (2018-2023)
Figure 46. United States Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Mental Disorders Drugs Sales Market Share by Region in 2022
Figure 51. APAC Mental Disorders Drugs Revenue Market Share by Regions in 2022
Figure 52. APAC Mental Disorders Drugs Sales Market Share by Type (2018-2023)
Figure 53. APAC Mental Disorders Drugs Sales Market Share by Application (2018-2023)
Figure 54. China Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Mental Disorders Drugs Sales Market Share by Country in 2022
Figure 62. Europe Mental Disorders Drugs Revenue Market Share by Country in 2022
Figure 63. Europe Mental Disorders Drugs Sales Market Share by Type (2018-2023)
Figure 64. Europe Mental Disorders Drugs Sales Market Share by Application (2018-2023)
Figure 65. Germany Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Mental Disorders Drugs Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Mental Disorders Drugs Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Mental Disorders Drugs Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Mental Disorders Drugs Sales Market Share by Application (2018-2023)
Figure 74. Egypt Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Mental Disorders Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Mental Disorders Drugs in 2022
Figure 80. Manufacturing Process Analysis of Mental Disorders Drugs
Figure 81. Industry Chain Structure of Mental Disorders Drugs
Figure 82. Channels of Distribution
Figure 83. Global Mental Disorders Drugs Sales Market Forecast by Region (2024-2029)
Figure 84. Global Mental Disorders Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Mental Disorders Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Mental Disorders Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Mental Disorders Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Mental Disorders Drugs Revenue Market Share Forecast by Application (2024-2029)